UB Paderborn / Katalog / Suche / in CDI

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

The lancet oncology, 2016-04, Vol.17 (4), p.532-538

2016

Link zum Volltext

Verfügbarkeit prüfen

Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France

The oncologist (Dayton, Ohio), 2019-08, Vol.24 (8), p.e775-e783

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

British journal of cancer, 2019-04, Vol.120 (9), p.913-921

2019

Link zum Volltext

Verfügbarkeit prüfen

Value of fine‐needle aspiration in evaluating large thyroid nodules

Head & neck, 2017-01, Vol.39 (1), p.32-36

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity

The Journal of pathology, 2004-07, Vol.203 (3), p.822-830

2004

Link zum Volltext

Verfügbarkeit prüfen

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer

Breast cancer research and treatment, 2010-11, Vol.124 (2), p.387-391

2010

Link zum Volltext

Verfügbarkeit prüfen

2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France

Annales de pathologie, 2021-11, Vol.41 (6), p.507-520

2021

Link zum Volltext

Verfügbarkeit prüfen

Prospective Trial on Probe-Based Confocal Laser Endomicroscopy for the Identification of the Distal Limit in Rectal Adenocarcinoma

Surgical innovation, 2018-08, Vol.25 (4), p.313-322

2018

Link zum Volltext

Verfügbarkeit prüfen

Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report

Applied immunohistochemistry & molecular morphology, 2015-03, Vol.23 (3), p.230

2015

Link zum Volltext

Verfügbarkeit prüfen

Lymphatic Mapping and Sentinel Node Biopsy of Operable Breast Cancer

World journal of surgery, 2000-10, Vol.24 (10), p.1220-1226

2000

Link zum Volltext

Verfügbarkeit prüfen

High inter-observer agreement in immunohistochemical evaluation of HER-2/ neu expression in breast cancer: A multicentre GEFPICS study

European journal of cancer (1990), 2006-11, Vol.42 (17), p.2946-2953

2006

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting

Clinical cancer research, 2001-06, Vol.7 (6), p.1577-1581

2001

Link zum Volltext

Verfügbarkeit prüfen

Analyse comparative des coûts de techniques de biologie moléculaire dans le diagnostic de sarcomes

Bulletin du cancer, 2013-10, Vol.100 (10), p.963-971

2013

Link zum Volltext

Verfügbarkeit prüfen

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

PloS one, 2021-02, Vol.16 (2), p.e0246958-e0246958

2021

Link zum Volltext

Verfügbarkeit prüfen

Cas no 4 : tumeur épithélioïde des tissus mous

Annales de pathologie, 2020-07, Vol.40, p.275-286

2020

Link zum Volltext

Verfügbarkeit prüfen

Cas no 4 : tumeur épithélioïde des tissus mous

Annales de pathologie, 2020-07, Vol.40 (4), p.275-286

2020

Link zum Volltext

Verfügbarkeit prüfen

Case 4: Epithelioid soft tissue tumor

Annales de pathologie, 2020-07, Vol.40 (4), p.275-286

2020

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of primary cutaneous angiosarcoma of the nose with sequential chemo- and radiotherapy

Clinical and translational radiation oncology, 2020-03, Vol.21, p.1-4

2020

Link zum Volltext

Verfügbarkeit prüfen

Une tumeur des tissus mous rare mais caractéristique

Annales de pathologie, 2005, Vol.25 (3), p.245-246

2005

Link zum Volltext

Verfügbarkeit prüfen

Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

Annales de pathologie, 2021-11, Vol.41 (6), p.507-520

2021

Link zum Volltext

Verfügbarkeit prüfen

Is docetaxel (D) less efficient than anthracycline-based chemotherapy (A) in triple-negative breast cancer (TNBC) treated in neoadjuvant setting?

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11542-e11542

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Value of fine‐needle aspiration in evaluating large thyroid nodules

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity

Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer

Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification

2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France

Prospective Trial on Probe-Based Confocal Laser Endomicroscopy for the Identification of the Distal Limit in Rectal Adenocarcinoma

Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report

GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting

Lymphatic Mapping and Sentinel Node Biopsy of Operable Breast Cancer

High inter-observer agreement in immunohistochemical evaluation of HER-2/ neu expression in breast cancer: A multicentre GEFPICS study

Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting

Analyse comparative des coûts de techniques de biologie moléculaire dans le diagnostic de sarcomes

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

Cas no 4 : tumeur épithélioïde des tissus mous

Cas no 4 : tumeur épithélioïde des tissus mous

Case 4: Epithelioid soft tissue tumor

Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study

Successful treatment of primary cutaneous angiosarcoma of the nose with sequential chemo- and radiotherapy

Une tumeur des tissus mous rare mais caractéristique

Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France

2021 update of the GEFPICS’ recommendations for HER2 status assessment in invasive breast cancer in France

Is docetaxel (D) less efficient than anthracycline-based chemotherapy (A) in triple-negative breast cancer (TNBC) treated in neoadjuvant setting?

Suchergebnisse filtern